期刊文献+

子宫内膜癌和子宫平滑肌瘤内皮抑素及CD34内皮祖细胞的表达及其意义 被引量:2

Study on the expression of endostatin and CD34 endothelial progenitor cells (EPCs) and its significance in endometrial adenocarcinoma and uterus myoma
下载PDF
导出
摘要 目的研究子宫内膜癌和子宫平滑肌瘤组织内皮抑素、内皮祖细胞(EPCs)的表达及其临床意义。方法应用免疫组化方法检测24例正常子宫内膜、68例子宫肌瘤和92例子宫内膜癌组织中内皮抑素及EPCs的表达,评价其与子宫内膜癌临床病理分期及病情发展的相关性。结果①内皮抑素蛋白的表达在正常子宫内膜与子宫平滑肌瘤之间无显著性差异,子宫内膜癌组织中内皮抑素表达明显高于正常子宫内膜组和子宫平滑肌瘤组。②子宫内膜癌CD34 EPCs表达与正常子宫内膜及子宫平滑肌瘤比较均有显著性差异。③临床期别越高,内皮抑素的表达越高,内皮抑素表达与临床手术分期相关(P<0.05)。④临床期别越高,组织分化越差,EPCs表达越高。临床手术分期、组织学分级、淋巴结转移和肌层浸润均与CD34 EPCs表达有关。⑤内皮抑素与EPCs的表达有显著相关性(r=0.708,P<0.01),内皮抑素水平越高,EPCs表达越多。结论子宫内膜癌组织内皮抑素和CD34 EPCs表达水平与子宫内膜癌的发生发展及患者预后有关。 Objective It is to investigate the expression of endostatin and endothelial progenitor cells(EPCs) and its significance in endometrial adenocarcinoma and uterus myoma.Methods The expression of endostatin and EPCs in 24 cases of normal endometrium,68 cases of uterus myoma and 92 cases of endometrial adenocarcinoma were examined by immunohistochemisry staining,and the correlations of them with the clinical pathological parameters and progression of disease with adenocarcinoma endometrial were analyzed.Results ①There was no significant difference in the expression of endostatin protein between normal endometrium and uterus myoma,but the expression of endostatin protein in endometrial adenocarcinoma was markedly higher than that in uterus myoma and normal endometrium.②There was significant difference in the expression of EPCs between endometrial adenocarcinoma and normal endometrium or uterus myoma.③The levels of endostatin protein expression in adenocarcinoma endometrial was significantly associated with clinical stage.④The levels of EPCs in adenocarcinoma endometrial was significantly associated with clinical stage,histological grades,lymph node metastasis and myometrial invasion.⑤The expression of endostatin was significantly associated with EPCs.Conclusion The expression of endostatin protein and EPCs may has a relationship with the development of endometrial adenocarcinoma and prognosis of the patients.
机构地区 河北省人民医院
出处 《现代中西医结合杂志》 CAS 2013年第20期2175-2177,2183,共4页 Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词 内皮抑素 子宫内膜癌 内皮祖细胞 子宫平滑肌瘤 免疫组织化学染色法 endostatin endometrial adenocarcinoma endothelial progenitor cells uterus myoma immunohistochemistry staining
  • 相关文献

参考文献7

  • 1D' Angelo MG,Afanasieva T,Aguzzi A. Angiogenesis in transgenic models of multistep carcinogenesis [ J ]. J Neurooncol, 2000,50 ( 1/ 2) :89 -98.
  • 2Kerbel RS. Inhibition of tumor angiogenesis as a strategy to circum- vent acquired resistance to anti-cancer therapeutic agents [ J ]. Bioessays,1991,13(1 ) :31 - 36.
  • 3O' Reilly MS, Boehm T, Shing Y, et al. Endostatin : an endogenous inhibitor of angiogenesis and tumor growth [ J ]. Cell, 1997,88 (2) : 277 -285.
  • 4Kaku T, Kamura T, Kinkawa N, et al. Angiogenesis in endometrial carcinoma [ J ]. Cancer, 1997,80 ( 4 ) :741 - 747.
  • 5Mo HY, Luo DH, Qiu HZ, et al. Elevated serum endostatin levels are associated with poor survival in patients with advanced-stage na- sopharyngeal carcinoma[J]. Clin Oncol (R Coil Radiol) ,2013,25 (5) :308 -317.
  • 6Eder JP Jr,Supko JG,Clark JW,et al. Phase I Clinical Trial of re- combinant human endostatin administered as a short intravenous in- fusion repeated daily[ J]. J Clin 0nco,2002,20( 18 ) :3772 - 3784.
  • 7Yokoyama Y, Dhanabal M,Griffioen AW,et al. Synergy between a- ngiostatin and endostatin : inhibition of ovarian cancer growth [ J ]. Cancer Research, 2000,60 ( 8 ) :2190 - 2196.

同被引文献20

  • 1Linkov F,Edwards RP,Althouse A,et al.Obesity,lymphadenectomy and survival outcomes in intermediate to highrisk,early-stage endometrial cancer patients[J].Future Oncol,2015,11(4):607-615.
  • 2Ryazantseva NV,Novitskii VV,Zhukova OB.Role of NF-k B,p53,and p21 in the regulation of TNF-alpha mediated apoptosis of lymphocytes[J].Bull Exp Biol Med,2010,149(1):50-53.
  • 3Gu XS,Lei JP,Shi JB,et al.Mimecan is involved in aortic hypertrophy induced by sinoaortic denervation in rats[J].Mol Cell Biochem,2011,352(1):309-316.
  • 4Zhu W,Wei L,Zhang H,et al.Oncolytic adenovirus armed with IL-24 inhibits the growth of breast cancer in vitro and in vivo[J].J Exp Clin Cancer Res,2012,31(1):51-55.
  • 5Haldorsen IS,Stefansson I,Gruner R,et al.Increased microvascular proliferation is negatively correlated to tumour blood flow and is associated with unfavourable outcome in endometrial carcinomas[J].Br J Cancer,2014,110(1):107-114.
  • 6Ahmad I,Iwata T,Leung HY.Mechanisms of FGFR-mediated carcinogenesis[J].Biochim Biophys Acta,2012,1823(4):850-860.
  • 7Weigelt B,Banerjee S.Molecular targets and targeted therapeutics in endometrial cancer[J].Curr Opin Oncol,2012,24(5):554-563.
  • 8Whitaker EL,Filippov VA,Duerksen-Hughes PJ.Interleukin 24:mechanisms and therapeutic potential of an anti-cancer gene[J].Cytokine Growth Factor Rev,2012,23(6):323-331.
  • 9郑寰宇,郑红宇,易建平,程建新.PTEN与VEGF蛋白在原发性卵巢癌中的表达及临床病理学意义[J].中国妇幼保健,2010,25(28):4128-4131. 被引量:1
  • 10童平珍,陈春燕,阳帅.B7-H4在胃腺癌中的表达及临床意义[J].贵州医药,2010,34(10):877-879. 被引量:1

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部